| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.877 | 134.183 | 234.833 | 373.203 | 842.323 |
| Total Income - EUR | - | - | - | - | - | 9.877 | 133.812 | 234.834 | 373.204 | 842.323 |
| Total Expenses - EUR | - | - | - | - | - | 12.786 | 133.823 | 224.689 | 327.271 | 796.739 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -2.909 | -11 | 10.145 | 45.933 | 45.585 |
| Net Profit/Loss - EUR | - | - | - | - | - | -3.008 | -1.341 | 7.796 | 42.124 | 38.095 |
| Employees | - | - | - | - | - | 1 | 2 | 3 | 3 | 10 |
Check the financial reports for the company - Farmacia Noastra S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 8.783 | 20.888 |
| Current Assets | - | - | - | - | - | 12.330 | 52.661 | 99.999 | 135.796 | 166.419 |
| Inventories | - | - | - | - | - | 9.427 | 30.839 | 36.177 | 45.837 | 66.535 |
| Receivables | - | - | - | - | - | 667 | 18.214 | 30.743 | 73.052 | 85.628 |
| Cash | - | - | - | - | - | 2.236 | 3.608 | 33.079 | 16.907 | 14.257 |
| Shareholders Funds | - | - | - | - | - | -2.966 | -4.241 | 3.542 | 42.172 | 29.774 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 15.296 | 56.902 | 96.457 | 102.407 | 157.533 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Noastra S.r.l.